| rdfs:label | "Zonisamide Mylan"@en |
| schema:description |
"pharmaceutical product"@en
|
|
schema:date |
"2023-11-17T13:56:45+00:00"^^xsd:dateTime |
| schema:version | 2012951526 |
| wikibase:identifiers | 1 |
| wikibase:sitelinks | 0 |
| wikibase:statements | 5 |
| p:P31 | wd:statement/Q29006754-2CD55EFE-BD1D-4847-B171-BACD3D7DB253 |
| wd:statement/Q29006754-3B7BFB92-7461-4E15-9D9C-79CF3B6DE349 | |
| p:P3637 | wd:statement/Q29006754-A5688A6B-5431-4043-BF0E-A39B2728F6C7 |
| p:P3781 | wd:statement/Q29006754-A2F50264-D101-4FB4-8024-4ABF55CF1D22 |
| p:P4044 | wd:statement/Q29006754-55BEFF0E-9B19-44AB-A1E9-8CD21BB085A0 |
| wdt:P31 | mixture |
| pharmaceutical product | |
| wdt:P3637 | "EMEA/H/C/004127" |
| wdt:P3781 | zonisamide |
| wdt:P4044 | epilepsy |
Download as: